Total Payments
$10,925
2024 Payments
$316.60
Companies
22
Transactions
182
Medicare Patients
12,203
Medicare Billing
$812,108
Payment Breakdown by Category
Other$7,950 (72.8%)
Food & Beverage$2,975 (27.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $7,950 | 3 | 72.8% |
| Food and Beverage | $2,975 | 179 | 27.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $8,774 | 58 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $752.49 | 40 | $0 (2023) |
| PFIZER INC. | $220.43 | 11 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $183.97 | 11 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $174.97 | 12 | $0 (2022) |
| Amgen Inc. | $156.14 | 10 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $141.72 | 10 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $63.71 | 4 | $0 (2019) |
| Amarin Pharma Inc. | $60.13 | 4 | $0 (2022) |
| Regeneron Healthcare Solutions, Inc. | $56.07 | 3 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $316.60 | 17 | Novartis Pharmaceuticals Corporation ($104.09) |
| 2023 | $388.29 | 25 | Novartis Pharmaceuticals Corporation ($166.97) |
| 2022 | $528.92 | 34 | Janssen Pharmaceuticals, Inc ($190.65) |
| 2021 | $366.48 | 22 | Janssen Pharmaceuticals, Inc ($215.83) |
| 2020 | $264.37 | 14 | Janssen Pharmaceuticals, Inc ($187.36) |
| 2019 | $5,809 | 33 | Novartis Pharmaceuticals Corporation ($5,454) |
| 2018 | $2,809 | 9 | Novartis Pharmaceuticals Corporation ($2,754) |
| 2017 | $442.81 | 28 | Amgen Inc. ($85.95) |
All Payment Transactions
182 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/14/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/23/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/22/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/13/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/26/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/06/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/23/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $17.78 | General |
| Category: Cardiovascular | ||||||
| 05/14/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $21.99 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/04/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $24.49 | General |
| Category: Not Applicable | ||||||
| 03/28/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/25/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/06/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $16.94 | General |
| Category: Cardiovascular | ||||||
| 02/27/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/15/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: Cardiology | ||||||
| 02/07/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $16.66 | General |
| Category: Cardiovascular | ||||||
| 01/25/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/19/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $20.92 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/08/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: DIABETES | ||||||
| 11/16/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/10/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/10/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $0.44 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/09/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $14.39 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/25/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/18/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $16.66 | General |
| Category: Cardiovascular | ||||||
| 09/28/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 2,959 | 3,529 | $912,219 | $201,260 |
| 2022 | 20 | 3,126 | 3,913 | $964,829 | $216,333 |
| 2021 | 21 | 3,226 | 4,088 | $1.0M | $221,345 |
| 2020 | 21 | 2,892 | 3,445 | $853,418 | $173,169 |
Total Patients
12,203
Total Services
14,975
Medicare Billing
$812,108
Procedure Codes
88
All Medicare Procedures & Services
88 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 706 | 917 | $233,835 | $80,387 | 34.4% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2023 | 38 | 38 | $76,038 | $23,556 | 31.0% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 75 | 77 | $141,988 | $17,961 | 12.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 275 | 281 | $116,615 | $14,362 | 12.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 119 | 119 | $47,005 | $13,741 | 29.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 78 | 151 | $27,180 | $9,238 | 34.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 65 | 68 | $23,120 | $6,668 | 28.8% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 102 | 103 | $69,010 | $5,865 | 8.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 82 | 85 | $14,914 | $5,366 | 36.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 405 | 422 | $37,980 | $4,085 | 10.8% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 50 | 103 | $10,300 | $3,587 | 34.8% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 415 | 499 | $27,477 | $2,848 | 10.4% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 133 | 133 | $13,300 | $2,097 | 15.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 14 | 14 | $7,000 | $1,935 | 27.6% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 46 | 114 | $11,400 | $1,621 | 14.2% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 37 | 80 | $8,800 | $1,539 | 17.5% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 32 | 34 | $6,265 | $1,525 | 24.3% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 133 | 133 | $19,950 | $1,395 | 7.0% |
| 78451 | Nuclear medicine study of heart muscle at rest and with stress and spect | Facility | 2023 | 20 | 20 | $8,600 | $986.07 | 11.5% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 15 | 15 | $3,825 | $867.23 | 22.7% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 80 | 84 | $4,692 | $843.87 | 18.0% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 39 | 39 | $2,925 | $785.85 | 26.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 679 | 1,016 | $259,080 | $88,674 | 34.2% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2022 | 38 | 38 | $76,038 | $25,416 | 33.4% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2022 | 62 | 64 | $118,016 | $15,079 | 12.8% |
About Dr. Patrick Murphy, M.D
Dr. Patrick Murphy, M.D is a Cardiovascular Disease healthcare provider based in Decatur, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1497703367.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Patrick Murphy, M.D has received a total of $10,925 in payments from pharmaceutical and medical device companies, with $316.60 received in 2024. These payments were reported across 182 transactions from 22 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($7,950).
As a Medicare-enrolled provider, Murphy has provided services to 12,203 Medicare beneficiaries, totaling 14,975 services with total Medicare billing of $812,108. Data is available for 4 years (2020–2023), covering 88 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Nuclear Cardiology, Pediatrics
- Location Decatur, IL
- Active Since 05/04/2006
- Last Updated 12/21/2021
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1497703367
Products in Payments
- ENTRESTO (Drug) $8,569
- XARELTO (Drug) $752.49
- ELIQUIS (Drug) $315.80
- LEQVIO (Drug) $204.78
- BRILINTA (Drug) $147.35
- LifeVest (Device) $141.72
- Corlanor (Drug) $102.47
- CAMZYOS (Drug) $68.04
- PRALUENT (Drug) $63.71
- Vascepa (Drug) $60.13
- Repatha (Biological) $53.67
- Veltassa (Drug) $49.75
- BYSTOLIC (Drug) $38.97
- JARDIANCE (Drug) $36.32
- NEXLETOL (Drug) $35.22
- PRALUENT (Biological) $32.32
- FARXIGA (Drug) $27.62
- Perclose ProGlide suture mediated closure system (Device) $26.27
- WATCHMAN Access System (Device) $25.66
- Arcalyst (Drug) $24.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Decatur
David Smull, Do, DO
Cardiovascular Disease — Payments: $108,965
Cardiovascular Disease $108,965
Jason Finkelstein, Md, MD
Cardiovascular Disease — Payments: $39,539
Cardiovascular Disease $39,539
Dr. Abhay Trivedi, Md, MD
Cardiovascular Disease — Payments: $14,235
Cardiovascular Disease $14,235
Luis Caceres, M.d, M.D
Cardiovascular Disease — Payments: $8,021
Cardiovascular Disease $8,021
Dr. Henock Zabher, M.d, M.D
Cardiovascular Disease — Payments: $7,914
Cardiovascular Disease $7,914
Mr. Peter Johnson, Md, MD
Cardiovascular Disease — Payments: $7,591
Cardiovascular Disease $7,591